Impact of Tissue Lipocalin-2 Expression on Pathologic Response and Prognosis Following Neoadjuvant Chemotherapy in Locally Advanced Triple-Negative Breast Cancer
Eurasian Journal of Medical Advances · 2026 · 66-74
DOI: 10.14744/ejma.260666 ↗Kurz gefasst
Fachartikel in der Zeitschrift Eurasian Journal of Medical Advances, 2026. Verfasst von Mehmet Emin Yılmaz und 8 weiteren Autor:innen.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Yılmaz, M. E., Ateş, Ö., Karabuğa, B., Aydemir, E., Kaya, O. B., Bolat, S. T., Büyükkör, M., Kurukafa, D., & Kandemir, O. (2026). Impact of Tissue Lipocalin-2 Expression on Pathologic Response and Prognosis Following Neoadjuvant Chemotherapy in Locally Advanced Triple-Negative Breast Cancer. Eurasian Journal of Medical Advances, 66-74. https://doi.org/10.14744/ejma.260666
Vancouver
Yılmaz ME, Ateş Ö, Karabuğa B, Aydemir E, Kaya OB, Bolat ST, et al. Impact of Tissue Lipocalin-2 Expression on Pathologic Response and Prognosis Following Neoadjuvant Chemotherapy in Locally Advanced Triple-Negative Breast Cancer. Eurasian Journal of Medical Advances. 2026:66-74. doi:10.14744/ejma.260666
BibTeX
@article{Ylmaz2026,
author = {Yılmaz, Mehmet Emin and Ateş, Öztürk and Karabuğa, Berkan and Aydemir, Ergin and Kaya, Osman Bilge and Bolat, Sedef Tatar and Büyükkör, Mustafa and Kurukafa, Diğdem and Kandemir, Olcay},
title = {Impact of Tissue Lipocalin-2 Expression on Pathologic Response and Prognosis Following Neoadjuvant Chemotherapy in Locally Advanced Triple-Negative Breast Cancer},
journal = {Eurasian Journal of Medical Advances},
year = {2026},
pages = {66--74},
doi = {10.14744/ejma.260666}
}
EUVIMED